GDF-15 is associated with worse ischemic and bleeding outcomes in the acute phase and during follow-up in patients with acute coronary syndrome: insights from the TRACER trial
Event:
ESC Congress 2023
Topic:
Epidemiology, Prognosis, Outcome
Session:
Risk stratification in acute coronary syndromes (1)